1. Show article details.

    U.S. Task Force to consider routine kidney disease screening

    Reuters – 7:16 AM ET 05/23/2022

    - An influential U.S. panel has added screening for chronic kidney disease to its list of preventive services under active consideration, the group's chair told Reuters, a move that could help identify patients eligible for new drugs that treat the disease earlier.

  2. Show article details.

    FOCUS-U.S. Task Force to consider routine kidney disease screening

    Reuters – 7:00 AM ET 05/23/2022

    An influential U.S. panel has added screening for chronic kidney disease to its list of preventive services under active consideration, the group's chair told Reuters, a move that could help identify patients eligible for new drugs that treat the disease earlier.

  3. Show article details.

    The Trials And Tribulations Of Psychedelic Research

    Benzinga – 1:00 PM ET 05/20/2022

    Microdose and appears here with permission. A growing body of research into the therapeutic use of psychedelics, including -- MDMA, psilocybin, LSD, ketamine, and DMT, are delivering promising results to treat a wide range of conditions such as post-traumatic stress disorder, depression, end-of-life anxiety, eating disorders, stroke, and chronic pain.

  4. Show article details.

    ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug

    Benzinga – 10:19 AM ET 05/20/2022

    ImmixBio's Lead Candidate Shows Improved Survival Over FDA-Approved Soft Tissue Cancer Drug

  5. Show article details.

    Vaccination after infection may curb long COVID; desktop 'air curtains' may deflect virus particles

    Reuters – 4:03 PM ET 05/19/2022

    - The following is a summary of some recent studies on COVID-19. Post-infection vaccination may reduce long COVID. Vaccination after infection with SARS-CoV-2 may contribute to a reduction in the burden of long COVID symptoms, a new study suggests.

  6. Show article details.

    COVID SCIENCE-Vaccination after infection may curb long COVID; desktop 'air curtains' may deflect virus particles

    Reuters – 3:59 PM ET 05/19/2022

    The following is a summary of some recent studies on COVID-19. Post-infection vaccination may reduce long COVID. Vaccination after infection with SARS-CoV-2 may contribute to a reduction in the burden of long COVID symptoms, a new study suggests.

  7. Show article details.

    What Are Whales Doing With Johnson & Johnson

    Benzinga – 12:02 PM ET 05/19/2022

    Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson. And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know. So how do we know what this whale just did?

  8. Show article details.

    India supplies non-J&J COVID shots under Quad umbrella

    Reuters – 9:50 AM ET 05/19/2022

    India has supplied COVID-19 vaccines to Cambodia and Thailand under an initiative of the Quad group of countries, New Delhi said on Thursday, though not the Johnson & Johnson (JNJ) shot as originally planned.

  9. Show article details.

    India has supplied COVID vaccines under Quad umbrella

    Reuters – 8:50 AM ET 05/19/2022

    India has supplied COVID-19 vaccines to Cambodia and Thailand under an initiative of the Quad group of countries that also includes the United States, Japan and Australia, New Delhi said on Thursday. The leaders of the Quad countries could discuss the vaccine supply plan when they meet in Japan next week, Indian foreign ministry spokesperson Arindam Bagchi told a news conference.

  10. Show article details.

    WHO clears COVID vaccine by China's CanSino Biologics for emergency use

    Reuters – 8:07 AM ET 05/19/2022

    The World Health Organization on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics (CASBF). The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.

  11. Show article details.

    Sector Rotation And 9 Stocks To Watch During A Recession

    Benzinga – 6:43 PM ET 05/18/2022

    Is the United States heading toward a recession? This has been the looming question on the minds of Americans since inflation topped at 8.5% in March, matched with other indicators such as rising interest rates and the bond market's inverted yield curve. Top economists are split on the inevitability of a recession.

  12. Show article details.

    Psychedelics Atai Life Sciences: Optimizing Drug Development By Avoiding Big Pharma's Past Missteps

    Benzinga – 1:14 PM ET 05/18/2022

    In the early days of the psychedelics industry, financial reports mean very little. According to Pharmaceutical Technology, Spravato has struggled to gain market traction since its high price tag and abuse potential often outweigh the significantly added efficacy.

  13. Show article details.

    INSIGHT-When Africans asked for COVID shots, they didn't get them. Now they don't want them

    Reuters – 3:00 AM ET 05/18/2022

    * Demand for COVID shots drops in Africa as supply rises. * Countries turn to mobile campaigns to boost uptake. * Africa, average age 20, has fared better in pandemic. * Experts warn new variants could emerge on continent. By Edward McAllister and Cooper Inveen. It's noisy inside the Mamprobi clinic in Accra as kids clamber over their mothers while they wait to get their measles vaccines.

  14. Show article details.

    8 Analysts Have This to Say About Johnson & Johnson

    Benzinga – 11:15 AM ET 05/17/2022

    Analysts have provided the following ratings for Johnson & Johnson within the last quarter: According to 8 analyst offering 12-month price targets in the last 3 months, Johnson & Johnson has an average price target of $193.5 with a high of $210.00 and a low of $173.00. Below is a summary of how these 8 analysts rated Johnson & Johnson over the past 3 months.

  15. Show article details.

    What you need to know about the coronavirus right now

    Reuters – 8:12 AM ET 05/13/2022

    Here's what you need to know about the pandemic right now: North Korea reports first COVID death as fever spreads 'explosively' At least one person confirmed to have COVID has died in North Korea and hundreds of thousands have shown fever symptoms, state media said on Friday, offering hints at the potentially dire scale of the country's first confirmed outbreak of the pandemic.

  16. Show article details.

    Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

    PR Newswire – 4:30 PM ET 05/12/2022

    NEW BRUNSWICK, N.J., May 12, 2022 Johnson & Johnson (JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16th.

  17. Show article details.

    Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock

    Benzinga – 3:36 PM ET 05/12/2022

    Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock

  18. Show article details.

    S.Africa's president says agencies should order Africa-made vaccines

    Reuters – 8:12 AM ET 05/12/2022

    * South African leader addresses global COVID summit. * Aspen's COVID vaccine capacity at risk. * WHO says lessons will be learnt from Aspen's plight. By Alexander Winning. International agencies and charitable foundations providing COVID-19 vaccines for Africa should order African-made vaccines, South African President Cyril Ramaphosa told a global COVID-19 summit on Thursday.

  19. Show article details.

    We will learn from plight of Aspen's S.African COVID vaccine plant - WHO

    Reuters – 6:47 AM ET 05/12/2022

    A senior World Health Organization official said on Thursday it was "unfortunate" that South African firm Aspen's COVID-19 production facility was at risk of closure for lack of orders but lessons would be learnt.

  20. Show article details.

    Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco

    Benzinga – 4:06 PM ET 05/11/2022

    Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco

Page:

Today's and Upcoming Events

  • Jul
    19

    JNJ to announce Q2 earnings (Confirmed)

  • May
    23

    JNJ ex-Dividend for $1.13 on 05/23/2022

    • Announce Date: 04/19/2022
    • Record Date: 05/24/2022
    • Pay Date: 06/07/2022

Past Events (last 90 days)

  • Apr
    19

    JNJ announced Q1 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.